Peptide Therapeutics Market Size, Trends, Share and Forecast Report 2022-2027

 Breaking News
  • No posts were found

Peptide Therapeutics Market Size, Trends, Share and Forecast Report 2022-2027

February 02
22:31 2023
Peptide Therapeutics Market Size, Trends, Share and Forecast Report 2022-2027
The global peptide therapeutics market reached a value of US$ 35.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2027, exhibiting a CAGR of 9.42% during 2022-2027.

According to the latest report by IMARC Group “Peptide Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global peptide therapeutics market reached a value of US$ 35.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2027, exhibiting a CAGR of 9.42% during 2022-2027.

Peptide therapeutics are drugs composed of peptides that are designed to cross the blood-brain barrier and allow them to target diseases of the central nervous system. They are precise and can target specific cells or proteins to reduce the likelihood of side effects. They are less toxic, relatively safer, and well-tolerated as compared to other treatment options.

Request for a free sample copy of this report: https://www.imarcgroup.com/peptide-therapeutics-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Peptide Therapeutics Market Trends and Drivers:

The surging prevalence of chronic diseases, such as obesity, diabetes, and cancer, represents one of the major factors driving the demand for peptide therapeutics around the world. Moreover, the increasing aging population, which is more prone to develop infectious diseases, and significant improvements in healthcare infrastructure is favoring the market growth. In addition, the rising use of peptide therapies in cosmetic surgeries to slow down the process of skin aging and the growing consciousness among individuals about physical appearance and the desire to retain young and healthy skin are influencing the market positively. Apart from this, there in an increase in the preferences for personalized medicines among individuals. This, along with the rising number of clinical trials by healthcare professionals to develop and execute precise non-invasive surgical procedures to treat autoimmune and inflammatory diseases, is contributing to the growth of the market.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Type:

  • Innovative
  • Generic

Breakup by Type of Manufacturer:

  • Outsourced
  • In-house

Breakup by Synthesis Technology:

  • Solid Phase Peptide Synthesis
  • Liquid Phase Peptide Synthesis
  • Hybrid Technology

Breakup by Routes of Administration:

  • Parenteral
  • Oral
  • Others

Breakup by Application:

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Amgen Inc.
  • Apitope International NV
  • Arch Biopartners Inc.
  • AstraZeneca plc
  • Circle Pharma Inc.
  • Corden Pharma GmbH
  • F. Hoffmann-La Roche AG
  • Ipsen Group
  • Lonza Group AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Zealand Pharma A/S.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4510&flag=C

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Other Trending Reports By IMARC Group

Newborn Screening Market

Healthcare CRM Market

Financial Fraud Detection Software Market

Eye Health Supplements Market

Aquaculture Market

Crude Oil Flow Improvers Market

Margarine Market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com

Categories